iSAM Funds (UK)’s Phibro Animal Health PAHC Stock Holding History

iSAM Funds (UK)’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,519	Closed	-$61.5K	–	603
2025 Q3	$61.5K	Buy	+1,519	New	+$50.2K	0.01%	542

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

iSAM Funds (UK)'s PAHC Position: Q4 2025 in Review

iSAM Funds (UK) sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 1,519 shares — an estimated $61.5K sold.

iSAM Funds (UK) first reported a position in PAHC in Q3 2025 and held it in 1 quarter. The position peaked at $61.5K in Q3 2025. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

iSAM Funds (UK) reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
iSAM Funds (UK) sold 1,519 Phibro Animal Health shares in Q4 2025, an estimated $61.5K.
iSAM Funds (UK) first reported a position in Phibro Animal Health in Q3 2025 and held it in 1 quarter.
iSAM Funds (UK)'s Phibro Animal Health position peaked at $61.5K in Q3 2025.
227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on iSAM Funds (UK)'s 13F filing for Q4 2025, filed 17 Feb 2026.